FI114102B - Menetelmä trombiinin vaikutuksesta pilkkoutuvan plasminogeenianalogin valmistamiseksi - Google Patents

Menetelmä trombiinin vaikutuksesta pilkkoutuvan plasminogeenianalogin valmistamiseksi Download PDF

Info

Publication number
FI114102B
FI114102B FI952071A FI952071A FI114102B FI 114102 B FI114102 B FI 114102B FI 952071 A FI952071 A FI 952071A FI 952071 A FI952071 A FI 952071A FI 114102 B FI114102 B FI 114102B
Authority
FI
Finland
Prior art keywords
vektor
plasminogen
cys
som
gly
Prior art date
Application number
FI952071A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952071A0 (fi
FI952071A (fi
Inventor
Keith Martyn Dawson
Michael George Hunter
Richard James Gilbert
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of FI952071A0 publication Critical patent/FI952071A0/fi
Publication of FI952071A publication Critical patent/FI952071A/fi
Application granted granted Critical
Publication of FI114102B publication Critical patent/FI114102B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
FI952071A 1992-10-29 1995-04-28 Menetelmä trombiinin vaikutuksesta pilkkoutuvan plasminogeenianalogin valmistamiseksi FI114102B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929222758A GB9222758D0 (en) 1992-10-29 1992-10-29 Proteins and nucleic acids
GB9222758 1992-10-29
GB9302219 1993-10-28
PCT/GB1993/002219 WO1994010318A1 (en) 1992-10-29 1993-10-28 Thrombin activatable plasminogen derivatives

Publications (3)

Publication Number Publication Date
FI952071A0 FI952071A0 (fi) 1995-04-28
FI952071A FI952071A (fi) 1995-04-28
FI114102B true FI114102B (fi) 2004-08-13

Family

ID=10724266

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952071A FI114102B (fi) 1992-10-29 1995-04-28 Menetelmä trombiinin vaikutuksesta pilkkoutuvan plasminogeenianalogin valmistamiseksi

Country Status (15)

Country Link
EP (1) EP0666920B1 (ja)
JP (1) JP3329340B2 (ja)
AT (1) ATE171213T1 (ja)
AU (1) AU674180B2 (ja)
CA (1) CA2145749C (ja)
DE (1) DE69321134T2 (ja)
DK (1) DK0666920T3 (ja)
ES (1) ES2123669T3 (ja)
FI (1) FI114102B (ja)
GB (1) GB9222758D0 (ja)
HK (1) HK1008047A1 (ja)
NO (1) NO317661B1 (ja)
NZ (1) NZ257175A (ja)
WO (1) WO1994010318A1 (ja)
ZA (1) ZA938120B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
CA2262751A1 (en) * 1996-08-02 1998-02-12 Roche Diagnostics Gmbh Plasminogen activator capable of being activated by thrombin
ES2296705T3 (es) 2000-12-21 2008-05-01 Thrombogenics N.V. Vector de expresion de levadura y metodo de produccion de una proteina recombinada por la expresion de una celula de levadura.
MXPA04007585A (es) * 2002-02-06 2005-09-20 N Zyme Biotec Gmbh Metodo para la produccion de proteinas recombinantes en microorganismos.
FR2841904B1 (fr) * 2002-07-03 2004-08-20 Inst Nat Sante Rech Med Analogues de facteurs x clivables par la thrombine
PL213309B1 (pl) 2006-02-09 2013-02-28 Polska Akademia Nauk Inst Biochemii I Biofizyki Sposób hydrolizy wiazania peptydowego

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids

Also Published As

Publication number Publication date
DK0666920T3 (da) 1999-06-14
ES2123669T3 (es) 1999-01-16
AU5343294A (en) 1994-05-24
HK1008047A1 (en) 1999-04-30
CA2145749C (en) 2005-06-21
FI952071A0 (fi) 1995-04-28
AU674180B2 (en) 1996-12-12
GB9222758D0 (en) 1992-12-09
NO317661B1 (no) 2004-11-29
NZ257175A (en) 1996-07-26
CA2145749A1 (en) 1994-05-11
JPH08504575A (ja) 1996-05-21
DE69321134D1 (de) 1998-10-22
JP3329340B2 (ja) 2002-09-30
EP0666920B1 (en) 1998-09-16
ZA938120B (en) 1994-08-01
NO951648L (no) 1995-04-28
DE69321134T2 (de) 1999-02-25
FI952071A (fi) 1995-04-28
WO1994010318A1 (en) 1994-05-11
NO951648D0 (no) 1995-04-28
EP0666920A1 (en) 1995-08-16
ATE171213T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
EP0502968B1 (en) Activatable fibrinolytic and anti-thrombotic proteins
KR970005251B1 (ko) 크링글 치환이 있는 돌연변이 이체 티-피에이
US5385732A (en) Variants of tissue plasminogen activator, compositions and methods of use for same
EP0424405B1 (en) Variants of plasminogen activators and processes for their production
FI114102B (fi) Menetelmä trombiinin vaikutuksesta pilkkoutuvan plasminogeenianalogin valmistamiseksi
EP0241210B1 (en) Modified enzyme
US5688664A (en) Thrombin activatable plasminogen analogues
US6869778B2 (en) Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
CA2163925A1 (en) Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
AU735519B2 (en) Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
CA2162986A1 (en) Proteins having fibrinolytic and coagulation-inhibiting properties
EP0292326A2 (en) Modified enzyme
WO1998021320A9 (en) TISSUE TYPE PLASMINOGEN ACTIVATOR (t-PA) VARIANTS: COMPOSITIONS AND METHODS OF USE
JP2000504941A (ja) トロンビンによって活性化され得るプラスミノーゲンアクチベーター
HU216870B (hu) Eljárás szöveti plazminogén aktivátor előállítására
HU210541A9 (hu) Zimogén- vagy fibrin-specifikus tulajdonságú, a 296-299 aminosav-tartományban helyettesített szöveti plazminogén aktivátor, ezt kódoló DNS-molekulák, vektorok és gazdasejtek